Pfizer Abandons Ionis’ Cardiovascular and High Triglyceride Program
Summary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe…
Summary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe…
On November 10, the Government of Jamaica deposited its instrument of accession to the Patent Cooperation Treaty (PCT) with WIPO’s Director General,…
Abstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor XELJANZ® (Tofacitinib) 5 mg twice daily for the treatment…
SUMMARY: Union Minister for Health and Family Welfare, Dr Mansukh Mandaviya launched the nationwide expansion of Pneumococcal Conjugate Vaccine (PCV) under the…
SUMMARY: Union Health Minister Mansukh Mandaviya on Thursday launched the sixth edition of the National Formulary of India published by Indian Pharmacopoeia Commission…